Agile Therapeutics Inc Empfehlungs-Mittelwert
Was ist das Empfehlungs-Mittelwert von Agile Therapeutics Inc?
Empfehlungs-Mittelwert von Agile Therapeutics Inc ist 1.00
Was ist die Definition von Empfehlungs-Mittelwert?
Der empfohlene Mittelwert ist der Durchschnitt der Analystenbewertungen der Aktie von 1,0 (starker Kauf) bis 5,0 (starker Verkauf).
Mean of recommendations is an average of ratings from different analysts but it should still be used with other research and investment metrics in order to make investment decisions. It is important to understand a firm's entire scale when assimilating ratings. Additionally, analyst recommendations on stocks owned by firms employing them may be seen as potentially biased.
Financial analysts are often employed by mutual and pension funds, hedge funds, securities firms, banks, investment banks, insurance companies, and other businesses, helping these companies or their clients make investment decisions. Financial analysts employed in commercial lending perform "balance sheet analysis," examining the audited financial statements and corollary data in order to assess lending risks. In a stock brokerage house or in an investment bank, they read company financial statements and analyze commodity prices, sales, costs, expenses, and tax rates in order to determine a company's value and project future earnings. In any of these various institutions, the analyst often meets with company officials to gain a better insight into a company's prospects and to determine the company's managerial effectiveness.
Usually, financial analysts study an entire industry, assessing current trends in business practices, products, and industry competition. They must keep abreast of new regulations or policies that may affect the industry, as well as monitor the economy to determine its effect on earnings.
Empfehlungs-Mittelwert von Unternehmen in Health Care Sektor auf NASDAQ im Vergleich zu Agile Therapeutics Inc
Was macht Agile Therapeutics Inc?
agile therapeutics is a forward-thinking women's healthcare company dedicated to fulfilling the unmet health needs of today's women. our product candidates are designed to provide women with contraceptive options that offer freedom from taking a daily pill, without committing to a longer-acting method. our lead product candidate, twirla®, (ethinyl estradiol and levonorgestrel transdermal system), also known as ag200-15, is a once-weekly prescription contraceptive patch that recently completed phase 3 trials. twirla is based on our proprietary transdermal patch technology, called skinfusion®, which is designed to provide advantages over currently available patches and is intended to optimize patch adhesion and patient wearability. for more information, please visit the company website at www.agiletherapeutics.com. connect with us on twitter at @agilether.
Unternehmen mit empfehlungs-mittelwert ähnlich Agile Therapeutics Inc
- Agile Therapeutics Inc hat Empfehlungs-Mittelwert von 1.00
- JOYY Inc hat Empfehlungs-Mittelwert von 1.05
- Honda Motor hat Empfehlungs-Mittelwert von 1.06
- Ares Capital Corp hat Empfehlungs-Mittelwert von 1.07
- Petroleo Brasileiro S.A. Petrobras hat Empfehlungs-Mittelwert von 1.08
- VNET Inc hat Empfehlungs-Mittelwert von 1.08
- Rocket Pharmaceuticals Inc hat Empfehlungs-Mittelwert von 1.08